CME Group Inc. (NASDAQ:CME) Shares Sold by Stonebrook Private Inc.

Stonebrook Private Inc. cut its holdings in shares of CME Group Inc. (NASDAQ:CME) by 2.1% during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 12,194 shares of the financial services provider’s stock after selling 265 shares during the quarter. Stonebrook Private Inc.’s holdings in CME Group were worth $2,832,000 as of its most recent SEC filing.

Other hedge funds also recently added to or reduced their stakes in the company. New Age Alpha Advisors LLC grew its position in shares of CME Group by 50.0% in the 4th quarter. New Age Alpha Advisors LLC now owns 129 shares of the financial services provider’s stock valued at $30,000 after buying an additional 43 shares during the last quarter. Avidian Wealth Enterprises LLC grew its position in shares of CME Group by 2.6% in the 4th quarter. Avidian Wealth Enterprises LLC now owns 1,769 shares of the financial services provider’s stock valued at $411,000 after buying an additional 45 shares during the last quarter. TFC Financial Management Inc. grew its position in shares of CME Group by 8.4% in the 4th quarter. TFC Financial Management Inc. now owns 592 shares of the financial services provider’s stock valued at $137,000 after buying an additional 46 shares during the last quarter. Waldron Private Wealth LLC grew its position in shares of CME Group by 2.0% in the 4th quarter. Waldron Private Wealth LLC now owns 2,362 shares of the financial services provider’s stock valued at $549,000 after buying an additional 47 shares during the last quarter. Finally, Venturi Wealth Management LLC grew its position in shares of CME Group by 12.1% in the 4th quarter. Venturi Wealth Management LLC now owns 437 shares of the financial services provider’s stock valued at $101,000 after buying an additional 47 shares during the last quarter. 87.75% of the stock is currently owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

Several research analysts have issued reports on the stock. Oppenheimer raised their price objective on shares of CME Group from $269.00 to $279.00 and gave the stock an “outperform” rating in a research report on Friday, April 11th. Bank of America raised their price objective on shares of CME Group from $200.00 to $219.00 and gave the stock an “underperform” rating in a research report on Wednesday, April 2nd. Piper Sandler raised their price objective on shares of CME Group from $275.00 to $283.00 and gave the stock an “overweight” rating in a research report on Tuesday, April 8th. Morgan Stanley raised their price objective on shares of CME Group from $301.00 to $304.00 and gave the stock an “overweight” rating in a research report on Thursday, April 24th. Finally, JPMorgan Chase & Co. lowered their price objective on shares of CME Group from $223.00 to $211.00 and set an “underweight” rating on the stock in a research report on Thursday, April 24th. Three research analysts have rated the stock with a sell rating, seven have issued a hold rating, five have assigned a buy rating and one has given a strong buy rating to the stock. According to data from MarketBeat, the stock currently has a consensus rating of “Hold” and a consensus target price of $256.80.

Insiders Place Their Bets

In other CME Group news, insider Hilda Harris Piell sold 3,984 shares of CME Group stock in a transaction dated Thursday, February 27th. The shares were sold at an average price of $250.47, for a total transaction of $997,872.48. Following the completion of the transaction, the insider now owns 27,046 shares in the company, valued at approximately $6,774,211.62. The trade was a 12.84% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Also, insider Derek Sammann sold 4,650 shares of CME Group stock in a transaction dated Monday, May 5th. The stock was sold at an average price of $280.61, for a total transaction of $1,304,836.50. Following the transaction, the insider now owns 8,336 shares of the company’s stock, valued at approximately $2,339,164.96. The trade was a 35.81% decrease in their position. The disclosure for this sale can be found here. Over the last quarter, insiders sold 23,134 shares of company stock worth $6,087,434. Insiders own 0.30% of the company’s stock.

CME Group Stock Up 0.8%

Shares of NASDAQ CME opened at $276.29 on Friday. The company has a quick ratio of 1.02, a current ratio of 1.01 and a debt-to-equity ratio of 0.10. CME Group Inc. has a 52 week low of $190.70 and a 52 week high of $286.48. The firm has a 50-day moving average price of $265.86 and a 200 day moving average price of $247.18. The stock has a market capitalization of $99.56 billion, a price-to-earnings ratio of 28.57, a price-to-earnings-growth ratio of 6.76 and a beta of 0.45.

CME Group (NASDAQ:CME) last announced its quarterly earnings data on Wednesday, April 23rd. The financial services provider reported $2.80 EPS for the quarter, beating the consensus estimate of $2.61 by $0.19. CME Group had a net margin of 57.52% and a return on equity of 13.62%. The firm had revenue of $1.64 billion during the quarter, compared to analysts’ expectations of $1.56 billion. During the same quarter last year, the business earned $2.50 earnings per share. The business’s revenue for the quarter was up 10.4% compared to the same quarter last year. Equities research analysts anticipate that CME Group Inc. will post 10.49 EPS for the current fiscal year.

CME Group Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, June 25th. Investors of record on Monday, June 9th will be paid a $1.25 dividend. This represents a $5.00 annualized dividend and a dividend yield of 1.81%. The ex-dividend date of this dividend is Monday, June 9th. CME Group’s dividend payout ratio (DPR) is 50.30%.

CME Group Company Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.